About this Journal Submit a Manuscript Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 548157, 17 pages
http://dx.doi.org/10.1155/2012/548157
Research Article

Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps

1United BioSource Corporation, Health Economics-Modeling and Simulation, 430 Bedford Street, Suite 300, Lexington, MA 02420, USA
2Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC) and VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132, USA
3Division of Aging, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Boston, MA 02120, USA
4Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
5United BioSource Corporation, Biostatistics, 430 Bedford Street, Suite 300, Lexington, MA 02420, USA
6Bayer HealthCare Pharmaceuticals, Global Market Access - General Medicine, 178 Müllerstraße, 13353 Berlin, Germany

Received 26 July 2012; Accepted 5 October 2012

Academic Editor: Francesco Panza

Copyright © 2012 Shien Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shien Guo, Denis Getsios, Luis Hernandez, et al., “Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps,” International Journal of Alzheimer’s Disease, vol. 2012, Article ID 548157, 17 pages, 2012. doi:10.1155/2012/548157